BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105 AND Treatment
15 results:

  • 1. Small Cell lung cancer Plasticity Enables NFIB-Independent Metastasis.
    Ko JH; Lambert KE; Bhattacharya D; Lee MC; Colón CI; Hauser H; Sage J
    Cancer Res; 2024 Jan; 84(2):226-240. PubMed ID: 37963187
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. foxa1-induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF-β signaling pathway.
    Wei J; Yu H; Liu T; Wang Z; Lang C; Pan Y
    Thorac Cancer; 2023 Jul; 14(21):2026-2037. PubMed ID: 37277890
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy and safety of anaplastic lymphoma kinase inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis.
    Peng TR; Liao PF; Wu TW
    Thorac Cancer; 2023 Apr; 14(10):929-939. PubMed ID: 36908264
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. foxa1 prevents nutrients deprivation induced autophagic cell death through inducing loss of imprinting of IGF2 in lung adenocarcinoma.
    Li J; Zhang Y; Wang L; Li M; Yang J; Chen P; Zhu J; Li X; Zeng Z; Li G; Xiong W; McCarthy JB; Xiang B; Yi M
    Cell Death Dis; 2022 Aug; 13(8):711. PubMed ID: 35974000
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma.
    Zewdu R; Mehrabad EM; Ingram K; Fang P; Gillis KL; Camolotto SA; Orstad G; Jones A; Mendoza MC; Spike BT; Snyder EL
    Elife; 2021 Apr; 10():. PubMed ID: 33821796
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer.
    Wang R; Yamada T; Kita K; Taniguchi H; Arai S; Fukuda K; Terashima M; Ishimura A; Nishiyama A; Tanimoto A; Takeuchi S; Ohtsubo K; Yamashita K; Yamano T; Yoshimura A; Takayama K; Kaira K; Taniguchi Y; Atagi S; Uehara H; Hanayama R; Matsumoto I; Han X; Matsumoto K; Wang W; Suzuki T; Yano S
    Nat Commun; 2020 Sep; 11(1):4607. PubMed ID: 32929081
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Age-correlated protein and transcript expression in breast cancer and normal breast tissues is dominated by host endocrine effects.
    Osako T; Lee H; Turashvili G; Chiu D; McKinney S; Joosten SEP; Wilkinson D; Nielsen TO; Zwart W; Emerman JT; Eaves CJ; Caldas C; Aparicio S
    Nat Cancer; 2020 May; 1(5):518-532. PubMed ID: 35121983
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/foxa1.
    Gou L; Zou H; Li B
    Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Knockdown of the lncRNA MALAT1 alleviates lipopolysaccharide‑induced A549 cell injury by targeting the miR‑17‑5p/foxa1 axis.
    Wei S; Wang K; Huang X; Tang W; Zhao Z; Zhao Z
    Mol Med Rep; 2019 Aug; 20(2):2021-2029. PubMed ID: 31257497
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. FOX-A1 contributes to acquisition of chemoresistance in human lung adenocarcinoma via transactivation of SOX5.
    Chen D; Wang R; Yu C; Cao F; Zhang X; Yan F; Chen L; Zhu H; Yu Z; Feng J
    EBioMedicine; 2019 Jun; 44():150-161. PubMed ID: 31147293
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. foxa1
    Liang J; Tian C; Zeng Y; Yang Q; Liu Y; Liu Y; Wu J; Hu Y; Gu F; Zhang K; Wang Y; Zhang Y; Liu L
    Biochem Biophys Res Commun; 2019 Jun; 514(1):308-315. PubMed ID: 31036318
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer.
    Huang C; Liu J; Xiong B; Yonemura Y; Yang X
    Gene; 2019 Feb; 685():202-210. PubMed ID: 30415009
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Concurrent Alterations in EGFR-Mutant lung cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance.
    Yu HA; Suzawa K; Jordan E; Zehir A; Ni A; Kim R; Kris MG; Hellmann MD; Li BT; Somwar R; Solit DB; Berger MF; Arcila M; Riely GJ; Ladanyi M
    Clin Cancer Res; 2018 Jul; 24(13):3108-3118. PubMed ID: 29530932
    [No Abstract]    [Full Text] [Related]  

  • 14. Role of transcription factor foxa1 in non‑small cell lung cancer.
    Li J; Zhang S; Zhu L; Ma S
    Mol Med Rep; 2018 Jan; 17(1):509-521. PubMed ID: 29115441
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PLOD2 regulated by transcription factor foxa1 promotes metastasis in NSCLC.
    Du H; Chen Y; Hou X; Huang Y; Wei X; Yu X; Feng S; Wu Y; Zhan M; Shi X; Lin S; Lu L; Yuan S; Sun L
    Cell Death Dis; 2017 Oct; 8(10):e3143. PubMed ID: 29072684
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.